RESUMEN
Pain management after total hip arthroplasty has improved dramatically in the past decade. However, most protocols use opioid medications for pain control. In the current study, 100 patients were prospectively selected to receive a traditional narcotic-based patient-controlled analgesia protocol or a nonnarcotic oral protocol for pain management after primary total hip arthroplasty. Therapy programs were similar for both groups. Postoperatively, patients were followed daily for opioid use, medication adverse effects, pain control, and overall satisfaction. The nonnarcotic oral group showed lower mean pain scores during the first 24 hours after surgery. The satisfaction rate was high in both groups. Both protocols provided adequate pain control after total hip arthroplasty; the nonnarcotic pain management protocol resulted in significantly decreased opioid consumption and fewer adverse effects.
Asunto(s)
Analgésicos no Narcóticos/uso terapéutico , Artroplastia de Reemplazo de Cadera/efectos adversos , Prótesis de Cadera , Narcóticos/uso terapéutico , Dolor Postoperatorio/tratamiento farmacológico , Acetaminofén/efectos adversos , Acetaminofén/uso terapéutico , Adulto , Anciano , Anciano de 80 o más Años , Analgésicos no Narcóticos/efectos adversos , Celecoxib , Dextropropoxifeno/efectos adversos , Dextropropoxifeno/uso terapéutico , Femenino , Fentanilo/efectos adversos , Fentanilo/uso terapéutico , Humanos , Masculino , Persona de Mediana Edad , Narcóticos/efectos adversos , Oxicodona/efectos adversos , Oxicodona/uso terapéutico , Dolor Postoperatorio/etiología , Satisfacción del Paciente , Pregabalina , Estudios Prospectivos , Pirazoles/efectos adversos , Pirazoles/uso terapéutico , Sulfonamidas/efectos adversos , Sulfonamidas/uso terapéutico , Encuestas y Cuestionarios , Resultado del Tratamiento , Ácido gamma-Aminobutírico/efectos adversos , Ácido gamma-Aminobutírico/análogos & derivados , Ácido gamma-Aminobutírico/uso terapéuticoRESUMEN
The purported advantages of mobile-bearing knee include increased survivorship and restoration of more natural knee kinematics compared to a standard fixed-bearing design. To evaluate these claims, an extensive review of the available literature was undertaken. We compared survivorship and clinical function, including patient preference. We found no difference in survivorship at 12 to 23 years. Kinematic profiles of both designs did not differ significantly: rotation, flexion, and extension were comparable. Studies evaluating both designs in the same patient showed no difference in range of motion, knee preference, knee scores, and survivorship at midterm follow-up. Both designs were capable of producing excellent long-term results and clinical outcomes if properly implanted. The available evidence does not point to the superiority of one design over another in survivorship and clinical function.